title: Management of venous thromboembolism.
abstract: Venous thromboembolism is a frequent cause of morbidity and mortality, especially in immobilized elderly patients. Once thrombosis exists, heparin is effective to arrest the process, and occasionally thrombolytic therapy with urokinase or streptokinase is indicated to accelerate lysis. Thrombosis may be prevented by one or a variety of prophylactic measures which should be applied in high-risk patients.
mesh_terms: D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000503:physiopathology; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D007537:Isometric Contraction; D009203:Myocardial Infarction / Q000150:complications; D011655:Pulmonary Embolism / Q000209:etiology; D013514:Surgical Procedures, Operative / Q000009:adverse effects; D013924:Thrombophlebitis / Q000517:prevention & control*
chemical_list: D005343:Fibrinolytic Agents; D006493:Heparin; D001241:Aspirin